Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Liver Cirrhosis

  Free Subscription


Articles published in Clin Res Hepatol Gastroenterol

Retrieve available abstracts of 52 articles:
HTML format



Single Articles


    June 2021
  1. QU Y, Li T, Lin C, Liu F, et al
    Animal Naming Test for the Assessment of Minimal Hepatic Encephalopathy in Asian Cirrhotic Populations.
    Clin Res Hepatol Gastroenterol. 2021 Jun 3:101729.
    PubMed     Abstract available


  2. RAZAQ S, Kara M, Ozcakar L
    Measure Grip Strength, Gait Speed and Quadriceps Muscle in Cirrhosis. Comment to "Frailty, sarcopenia and mortality in cirrhosis: What is the best assessment, how to interpret the data correctly and what interventions are possible?"
    Clin Res Hepatol Gastroenterol. 2021 Jun 1:101727.
    PubMed    


    April 2021
  3. OZCELIK F
    Prognostic value of gamma-glutamyl transpeptidase in liver cirrhosis and hepatocellular cancer regardless of other parameters.
    Clin Res Hepatol Gastroenterol. 2021 Apr 27:101708.
    PubMed    


  4. CARDOSO CC, Matiollo C, Pereira CHJ, Fonseca JS, et al
    B-cell compartment abnormalities are associated with ACLF and mortality in patients with liver cirrhosis.
    Clin Res Hepatol Gastroenterol. 2021 Apr 11:101698.
    PubMed     Abstract available


    March 2021
  5. TORNAI D, Vitalis Z, Jonas A, Janka T, et al
    Increased sTREM-1 levels identify cirrhotic patients with bacterial infection and predict their 90-day mortality.
    Clin Res Hepatol Gastroenterol. 2021;45:101579.
    PubMed     Abstract available


  6. CAO X, Cao Z, Ou C, Zhang L, et al
    Combination of serum paraoxonase/arylesterase 1 and antithrombin-III is a promising non-invasion biomarker for discrimination of AFP-negative HCC versus liver cirrhosis patients.
    Clin Res Hepatol Gastroenterol. 2021;45:101583.
    PubMed     Abstract available


  7. LANTHIER N, Starkel P, Dahlqvist G
    Frailty, sarcopenia and mortality in cirrhosis: what is the best assessment, how to interpret the data correctly and what interventions are possible?
    Clin Res Hepatol Gastroenterol. 2021 Mar 2:101661.
    PubMed     Abstract available


  8. DI GIORGIO A, Nicastro E, Arnaboldi S, Montini O, et al
    "Health status of children with chronic liver disease during the SARS-CoV-2 outbreak: results from a multicentre study".
    Clin Res Hepatol Gastroenterol. 2021;45:101610.
    PubMed    


    February 2021
  9. GAO Y, Liu H, Tang F, Zhang X, et al
    Efficacy and safety of anticoagulants in liver cirrhosis patients with portal vein thrombosis: A meta-analysis.
    Clin Res Hepatol Gastroenterol. 2021 Feb 15:101649.
    PubMed     Abstract available


    November 2020
  10. HUANG C, Seah JJ, Tan CK, Kam JW, et al
    Modified AST to platelet ratio index improves APRI and better predicts advanced fibrosis and liver cirrhosis in patients with non-alcoholic fatty liver disease.
    Clin Res Hepatol Gastroenterol. 2020 Nov 29:101528.
    PubMed     Abstract available


    September 2020
  11. MONTASSER IF, Ibrahim AA, Farid HM, Al Balakosy AM, et al
    De novo hepatocellular carcinoma in cirrhotic hepatitis C virus: Are directly acting antivirals beneficial?
    Clin Res Hepatol Gastroenterol. 2020 Sep 5. pii: S2210-7401(20)30212.
    PubMed     Abstract available


    August 2020
  12. ELKRIEF L, Houssel-Debry P, Ackermann O, Franchi-Abella S, et al
    Portal cavernoma or chronic non cirrhotic extrahepatic portal vein obstruction.
    Clin Res Hepatol Gastroenterol. 2020 Aug 17. pii: S2210-7401(20)30091.
    PubMed     Abstract available


    July 2020
  13. TRIPON S, Mayer P, Svab A, Habersetzer F, et al
    Intraabdominal urokinase in the treatment of loculated infected ascites in cirrhosis.
    Clin Res Hepatol Gastroenterol. 2020 Jul 9. pii: S2210-7401(20)30181.
    PubMed     Abstract available


    May 2020
  14. HEURGUE A, Habes D, Brugel M, Franchi-Abella S, et al
    Recent (non-cirrhotic) extrahepatic portal vein obstruction.
    Clin Res Hepatol Gastroenterol. 2020 May 21. pii: S2210-7401(20)30074.
    PubMed    


    April 2020
  15. ABERGEL A, Gasperment M, Nery FG, Buchard B, et al
    Extrahepatic portal vein obstruction (EHPVO) in cirrhosis.
    Clin Res Hepatol Gastroenterol. 2020 Apr 17. pii: S2210-7401(20)30089.
    PubMed    


    January 2020
  16. PETA V, Zhu J, Lubman DM, Huguet S, et al
    Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease.
    Clin Res Hepatol Gastroenterol. 2020 Jan 18. pii: S2210-7401(19)30272.
    PubMed     Abstract available


  17. HEDJOUDJE A, Cervoni JP, Patry C, Chatot M, et al
    Takotsubo cardiomyopathy triggered by delirium tremens in a cirrhotic patient with acute-on-chronic liver failure: A case report.
    Clin Res Hepatol Gastroenterol. 2020 Jan 9. pii: S2210-7401(19)30262.
    PubMed     Abstract available


    December 2019
  18. ZARSKI JP, David-Tchouda S, Trocme C, Margier J, et al
    Non-invasive fibrosis tests to predict complications in compensated post-hepatitis C cirrhosis.
    Clin Res Hepatol Gastroenterol. 2019 Dec 12. pii: S2210-7401(19)30256.
    PubMed     Abstract available


    November 2019
  19. ALLAIRE M, Cadranel JF, Nguyen TTN, Garioud A, et al
    Management of infections in patients with cirrhosis in the context of increasing therapeutic resistance: A systematic review.
    Clin Res Hepatol Gastroenterol. 2019 Nov 6. pii: S2210-7401(19)30224.
    PubMed     Abstract available


    October 2019
  20. ALLAIRE M, Walter A, Sutter O, Nahon P, et al
    TIPS for management of portal-hypertension-related complications in patients with cirrhosis.
    Clin Res Hepatol Gastroenterol. 2019 Oct 26. pii: S2210-7401(19)30217.
    PubMed     Abstract available


    August 2019
  21. VAZ NF, da Cunha VNR, Cunha-Silva M, Seva-Pereira T, et al
    Evolution of diagnostic criteria for acute kidney injury in patients with decompensated cirrhosis: A prospective study in a tertiary university hospital.
    Clin Res Hepatol Gastroenterol. 2019 Aug 16. pii: S2210-7401(19)30169.
    PubMed     Abstract available


  22. WANLESS IR
    Quantitative SHG-microscopy: Unraveling the nano-architecture of the cirrhotic liver.
    Clin Res Hepatol Gastroenterol. 2019 Aug 12. pii: S2210-7401(19)30174.
    PubMed    


    June 2019
  23. LIBERAL R, Gaspar R, Lopes S, Macedo G, et al
    Primary biliary cholangitis in patients with inflammatory bowel disease.
    Clin Res Hepatol Gastroenterol. 2019 Jun 3. pii: S2210-7401(19)30099.
    PubMed     Abstract available


    March 2019
  24. YANG F, Ren H, Gao Y, Zhu Y, et al
    The value of severe vitamin D deficiency in predicting the mortality risk of patients with liver cirrhosis: A meta-analysis.
    Clin Res Hepatol Gastroenterol. 2019 Mar 29. pii: S2210-7401(19)30052.
    PubMed     Abstract available


  25. HUNG TH, Tsai CC, Lee HF
    Population-based study of Entecavir and long-term mortality in chronic hepatitis B-related decompensated liver cirrhosis.
    Clin Res Hepatol Gastroenterol. 2019 Mar 25. pii: S2210-7401(19)30049.
    PubMed     Abstract available


    February 2019
  26. GUILLAUD O, Dumortier J, Traclet J, Restier L, et al
    Assessment of liver fibrosis by transient elastography (Fibroscan((R))) in patients with A1AT deficiency.
    Clin Res Hepatol Gastroenterol. 2019;43:77-81.
    PubMed     Abstract available


  27. YU C, Wang L, Xue H, Lin H, et al
    Association of glycated hemoglobin with the risk of advanced fibrosis in non-alcoholic fatty liver disease patients without diabetes.
    Clin Res Hepatol Gastroenterol. 2019;43:58-66.
    PubMed     Abstract available


  28. CASTRO NARRO GE, Consuelo Sanchez A, Salazar Martinez A, Gamboa Dominguez A, et al
    The silent course of liver steatosis and fibrosis in an adult patient with Cholesteryl Ester Storage Disease.
    Clin Res Hepatol Gastroenterol. 2019;43:e4-e6.
    PubMed    


    January 2019
  29. LEBRAY P, Varnous S
    Combined heart and liver transplantation: State of knowledge and outlooks.
    Clin Res Hepatol Gastroenterol. 2019 Jan 8. pii: S2210-7401(18)30173.
    PubMed     Abstract available


    December 2018
  30. BERGERE M, Erard-Poinsot D, Boillot O, Valette PJ, et al
    Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe.
    Clin Res Hepatol Gastroenterol. 2018 Dec 18. pii: S2210-7401(18)30268.
    PubMed     Abstract available


    October 2018
  31. RAMADAN HK, Makhlouf NA, Mahmoud AA, Abd Elrhman M, et al
    Role of vitamin D deficiency as a risk factor for infections in cirrhotic patients.
    Clin Res Hepatol Gastroenterol. 2018 Oct 11. pii: S2210-7401(18)30182.
    PubMed     Abstract available


    August 2018
  32. WANG C, Huang Z, Huang X, Liu C, et al
    Surgical outcomes between patients with and without a cirrhotic liver undergoing laparoscopic liver resection: A meta-analysis.
    Clin Res Hepatol Gastroenterol. 2018 Aug 10. pii: S2210-7401(18)30120.
    PubMed     Abstract available


    March 2018
  33. BIHARI C, Patil A, Sarin SK
    Adequate platelet counts in cirrhosis for laboratory-based optimum platelet functions.
    Clin Res Hepatol Gastroenterol. 2018 Mar 31. pii: S2210-7401(18)30044.
    PubMed    


  34. SUH SW, Choi YS, Hong SA, Kang H, et al
    Preoperative erythropoietin treatment improves survival following major hepatic resection in a cirrhotic rat model.
    Clin Res Hepatol Gastroenterol. 2018 Mar 23. pii: S2210-7401(17)30268.
    PubMed     Abstract available


  35. HUNG TH, Lee HF, Tseng CW, Tsai CC, et al
    Effect of proton pump inhibitors in hospitalization on mortality of patients with hepatic encephalopathy and cirrhosis but no active gastrointestinal bleeding.
    Clin Res Hepatol Gastroenterol. 2018 Mar 15. pii: S2210-7401(17)30267.
    PubMed     Abstract available


  36. MALLET M, Weiss N, Thabut D, Rudler M, et al
    Why and when to measure ammonemia in cirrhosis?
    Clin Res Hepatol Gastroenterol. 2018 Mar 15. pii: S2210-7401(18)30031.
    PubMed     Abstract available


    December 2017
  37. SANG W, Lv B, Li K, Lu Y, et al
    Therapeutic efficacy and safety of umbilical cord mesenchymal stem cell transplantation for liver cirrhosis in Chinese population: A meta-analysis.
    Clin Res Hepatol Gastroenterol. 2017 Dec 6. pii: S2210-7401(17)30259.
    PubMed     Abstract available


    November 2017
  38. BRUSTIA R, Savier E, Scatton O
    Physical exercise in cirrhotic patients: Towards prehabilitation on waiting list for liver transplantation. A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2017 Nov 18. pii: S2210-7401(17)30214.
    PubMed     Abstract available


    October 2017
  39. ZHANG CH, Zheng L, Gui L, Lin JY, et al
    Soluble epoxide hydrolase inhibition with t-TUCB alleviates liver fibrosis and portal pressure in carbon tetrachloride-induced cirrhosis in rats.
    Clin Res Hepatol Gastroenterol. 2017 Oct 11. pii: S2210-7401(17)30187.
    PubMed     Abstract available


  40. LEMOINNE S, Marteau P
    Gut microbial profile in primary biliary cholangitis: Towards bioindicators.
    Clin Res Hepatol Gastroenterol. 2017;41:507-508.
    PubMed    


    September 2017
  41. MURATORI P, Muratori L
    Autoantibodies in antimithocondrial antibodies negative primary biliary cholangitis.
    Clin Res Hepatol Gastroenterol. 2017;41:e47.
    PubMed    


    August 2017
  42. MA X, Sun D, Li C, Ying J, et al
    Statin use and virus-related cirrhosis: A systemic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2017 Aug 30. pii: S2210-7401(17)30180.
    PubMed     Abstract available


    May 2017
  43. MASCIA C, Lichtner M, Zuccala P, Vita S, et al
    Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-gamma)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection.
    Clin Res Hepatol Gastroenterol. 2017 May 31. pii: S2210-7401(17)30098.
    PubMed     Abstract available


    April 2017
  44. SAXENA P, Bihari C, Mirza R, Bhadoria AS, et al
    Exogenous growth factor based regenerative therapy in alcoholic cirrhosis patients renders limited effect on hemostatic elements.
    Clin Res Hepatol Gastroenterol. 2017 Apr 12. pii: S2210-7401(17)30080.
    PubMed    


    March 2017
  45. JAMSHIDZADEH A, Heidari R, Latifpour Z, Ommati MM, et al
    Carnosine ameliorates liver fibrosis and hyperammonemia in cirrhotic rats.
    Clin Res Hepatol Gastroenterol. 2017 Mar 7. pii: S2210-7401(17)30009.
    PubMed     Abstract available


    February 2017
  46. LI K, Liu H, Guo T
    Th17/Treg imbalance is an indicator of liver cirrhosis process and a risk factor for HCC occurrence in HBV patients.
    Clin Res Hepatol Gastroenterol. 2017 Feb 3. pii: S2210-7401(17)30003.
    PubMed     Abstract available


  47. GRANT CR, Liberal R
    Liver immunology: How to reconcile tolerance with autoimmunity.
    Clin Res Hepatol Gastroenterol. 2017;41:6-16.
    PubMed     Abstract available


  48. WATSON A, Bul V, Staudacher J, Carroll R, et al
    The predictors of mortality and secular changes in management strategies in emphysematous gastritis.
    Clin Res Hepatol Gastroenterol. 2017;41:e1-e7.
    PubMed     Abstract available


    December 2016
  49. ZHENG L, Qin J, Sun L, Gui L, et al
    Intrahepatic upregulation of MRTF-A signaling contributes to increased hepatic vascular resistance in cirrhotic rats with portal hypertension.
    Clin Res Hepatol Gastroenterol. 2016 Dec 30. pii: S2210-7401(16)30203.
    PubMed     Abstract available


    June 2016
  50. JARUVONGVANICH V, Sanguankeo A, Klomjit N, Upala S, et al
    Effects of caffeine consumption in patients with chronic hepatitis C: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2016 Jun 24. pii: S2210-7401(16)30089.
    PubMed     Abstract available


    November 2015
  51. ABERGEL A, Rotily M, Branchoux S, Akremi R, et al
    Chronic hepatitis C: Burden of disease and cost associated with hospitalisations in France in 2012 (The HEPC-LONE study).
    Clin Res Hepatol Gastroenterol. 2015 Nov 3. pii: S2210-7401(15)00246.
    PubMed     Abstract available


    October 2015
  52. GAO PJ, Gao J, Li Z, Hu ZP, et al
    Liver transplantation in adults with portal vein thrombosis: Data from the China Liver Transplant Registry.
    Clin Res Hepatol Gastroenterol. 2015 Oct 20. pii: S2210-7401(15)00121.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: